Seeking Alpha

AbbVie (ABBV) has sought an injunction to stop the European Medicines Agency from releasing...

AbbVie (ABBV) has sought an injunction to stop the European Medicines Agency from releasing "confidential" and "commercially-sensitive" trial-data about Humira, the company's blockbuster rheumatoid arthritis drug. AbbVie's lawsuit follows two Freedom of Information requests to the agency last year for "raw data" about the medicine's safety and efficacy, including from Belgian drug company UCB.
Comments (1)
  • tobott1
    , contributor
    Comments (5) | Send Message
     
    What ever happened to "proprietary concepts"...I think they still apply to socialist economies.
    11 Mar 2013, 01:22 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|